Quality and impact of eviQ Cancer Treatments Online (www.eviq.org.au): the medical oncologist's perspective

Loke, Lydia Py.; Chen, Tina Y.T.; Lewis, Craig; Ward, Robyn L.; Rushton, Shelley; Shapiro, Jeremy

doi:10.1111/ajco.12689

Cited by 2 publications

(3 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The eviQ evidence-based cancer treatment protocols [7] are an embedded part of regular cancer care within SWSLHD, and consequently many of the care plans configured in Mosaiq reflect these precisely. For a proportion of care plan assignments, the eviQ protocol is therefore known, and thus the full intended treatment protocol can be inferred.…”

Section: Setting and Populationmentioning

confidence: 99%

Visualising Variation in the Real-World Clinical Delivery of Chemotherapy Protocols

Kennedy,

Stevens,

Churches

2024

Studies in Health Technology and Informatics

View full text Add to dashboard Cite

Typical univariate measures of variation in chemotherapy protocols fail to capture and describe the full multi-dimensional complexity of treatment adjustments in real-world data. In this preliminary work, we propose novel visualisations of observed treatment events, as well as treatment-as-delivered relative to initial prescriptions, as a means of gaining insights into complex patterns of treatment variation in cancer patients. Simple clustering techniques were also used to confirm the utility of these visualisations and our ability to correlate observed variations with historical events.

show abstract

Section: Setting and Populationmentioning

confidence: 99%

Visualising Variation in the Real-World Clinical Delivery of Chemotherapy Protocols

Kennedy,

Stevens,

Churches

2024

Studies in Health Technology and Informatics

View full text Add to dashboard Cite

show abstract

“…[5][6][7][8] Previous work has documented users and early usage of eviQ 9,10 and the perspectives of medical oncologists only, on the quality and impact of eviQ. 11 Expanding on this, a mixed-method evaluation was conducted in 2020−2022 to understand current eviQ usage and the extent to which the Program is meeting its intended outcomes and, importantly, providing value to its broad user base. This evaluation was underpinned by a theory of change (Appendix A) which captured foundational activities and the intended program outcomes, including broader program goals of delivering the best evidence-based treatment and care and improving patient health outcomes.…”

Section: Introductionmentioning

confidence: 99%

“…Previous work has documented users and early usage of eviQ 9,10 and the perspectives of medical oncologists only, on the quality and impact of eviQ 11 . Expanding on this, a mixed‐method evaluation was conducted in 2020−2022 to understand current eviQ usage and the extent to which the Program is meeting its intended outcomes and, importantly, providing value to its broad user base.…”

Section: Introductionmentioning

confidence: 99%

eviQ Cancer Treatments Online: Providing evidence‐based information to improve cancer patient outcomes

Shingleton,

Stapleton,

Kelly

et al. 2024

Asia-Pac J Clncl Oncology

View full text Add to dashboard Cite

AimTo understand the current usage of eviQ Cancer Treatments Online (www.eviQ.org.au), an Australian, open‐access website providing evidence‐based and consensus‐driven cancer treatment protocols and information, and the extent to which it is meeting its intended outcomes and providing value to its users.MethodsA mixed‐method evaluation was conducted in 2020−2022 which included a review of key program documentation and website usage data, and delivery of a focused online survey to its users.ResultsIn 2022, 329 clinicians representing all Australian states and territories contributed to eviQ content development and review. eviQ content continues to grow with a 15.2% increase in total content from 2019 to 2022. eviQ website users continue to grow with 90,000 total monthly users in 2022, representing a 166% increase from 2018. The proportion of international users compared to Australian users continues to grow with 57% of total users in Australia and 43% international in 2022.Of 466 survey responses, the most cited reason for eviQ use was for information on side effects/toxicity (67%). Ninety‐three percent (93%) of respondents either agreed or strongly agreed that eviQ contributed to both health professionals providing the best evidence‐based treatment and care and improving the standardization of treatment and care provided.Conclusion eviQ is embedded in Australian clinical practice, highly valued, and relied upon by users. Users agree that eviQ has a positive impact on patients by supporting the delivery of evidence‐based treatment and that eviQ contributed to patients’ improved health outcomes and quality of life. eviQ's increasing international usage should be explored.

show abstract

Quality and impact of eviQ Cancer Treatments Online (www.eviq.org.au): the medical oncologist's perspective

Abstract: eviQ was highly regarded by Australian medical oncologists who responded to our survey. The results suggested that usage of eviQ had a positive impact on individual knowledge, practice and promoted better patient-centered care.

Cited by 2 publications

References 3 publications

Visualising Variation in the Real-World Clinical Delivery of Chemotherapy Protocols

Visualising Variation in the Real-World Clinical Delivery of Chemotherapy Protocols

eviQ Cancer Treatments Online: Providing evidence‐based information to improve cancer patient outcomes

Contact Info

Product

Resources

About